Status:
COMPLETED
Arthroscopic Shoulder Surgery With Administration of Intravenous Tranexamic Acid
Lead Sponsor:
National Cheng-Kung University Hospital
Conditions:
Rotator Cuff Tears
Shoulder Arthorscopy Surgery
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Purpose: The study aimed to determine whether intravenous administration of tanexamic acid (TXA) before shoulder arthroscopic rotator cuff repair surgery can improve arthroscopy visual clarity. Method...
Eligibility Criteria
Inclusion
- Patients who were diagnosed with rotator cuff tear and failure of conservative treatment for more than 3 months. The tear size was measured by MRI and must be repairable.
Exclusion
- Acute traumatic rotator cuff tear.
- History of coagulopathy
- Under anticoagulation therapy before surgery
- Abnormal coagulation profile (prothrombin time or activated partial thromboplastin time) before surgery
- Renal or liver disorder
- Uncontrolled hypertension (baseline systolic pressure \>180 mmHg)
- Allergy to local anesthetic agent or TXA.
Key Trial Info
Start Date :
June 7 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2018
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04025736
Start Date
June 7 2017
End Date
February 28 2018
Last Update
July 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cheng Kung University Hospital
Tainan, Taiwan, 704